SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (9631)12/2/2003 10:24:05 AM
From: Icebrg  Read Replies (1) | Respond to of 52153
 
>>Anyone done any digging into the ASH abstracts?>>

You have the drug/indication that is going to "save" Alexion. Only a confirmation of what has already been reported, but still. You don't see results like this too often. And it is an unmet medical need as far as I know. Alexion has been very strong lately although it should be weak due to concerns over pexelizumab.

Erik

Message 19470065